Open House Discount Agreements for Sitagliptin and Ertugliflozin

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 583 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Sitagliptin und Ertugliflozin, ATC A10BD24

60/100

Score d'opportunité

PromisingLow complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

60 / 100

Complexité

20 / 100

Facteurs de risque

No estimated contract value or minimum volume; actual business depends on utilisation.

Contracts will automatically cease if nationwide or regional discount agreements for the same drug are concluded under...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Strong opportunity

Faits clés

Framework procurement
Supplies contract
1 lot
Duration until May 2028
Non-exclusive discount agreements on pharmaceutical products containing Sitagliptin and Ertugliflozin (ATC A10BD24).
Contracts run from 01.06.2026 to 31.05.2028.

Afficher le résumé complet

This is an Open House model (not a standard procurement) by AOK Bayern for non-exclusive discount agreements on pharmaceutical products containing Sitagliptin and Ertugliflozin (ATC A10BD24) under §130c SGB V. All interested pharmaceutical companies meeting the eligibility criteria can join on identical terms. Contracts run from 01.06.2026 to 31.05.2028. No estimated value provided.

Risques

No estimated contract value or minimum volume; actual business depends on utilisation.

Contracts will automatically cease if nationwide or regional discount agreements for the same drug are concluded under...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

Only pharmaceutical companies are eligible.

Administrative

Must submit signed contract, signed annex listing covered medicines, and signed declaration of reliability.
Submission: either paper (two original copies) or electronic with qualified electronic signature via DTVP portal.

Acheteur

Nom

AOK Bayern - Die Gesundheitskasse

Localisation

München, DEU

[email protected]

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open House Discount Agreements for Sitagliptin and Ertugliflozin

Non-exclusive discount agreements for Sitagliptin and Ertugliflozin (ATC A10BD24). Contract period 01.06.2026–31.05.2028. Joining possible anytime until 03.04.2028. No selection; all eligible pharmaceutical companies can participate.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

May 2026 - May 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Apr 03, 2028

Détails de la procédure

Date de publication: 14 Apr 2026
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 254718-2026

Documents (2)

Document de consultation 1 Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3